Jasemine C. Chambers

Array ( [id] => 3812750 [patent_doc_number] => 05789244 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-04 [patent_title] => 'Compositions and methods for the treatment of cancer using recombinant viral vector delivery systems' [patent_app_type] => 1 [patent_app_number] => 8/584077 [patent_app_country] => US [patent_app_date] => 1996-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5091 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/789/05789244.pdf [firstpage_image] =>[orig_patent_app_number] => 584077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3714565 [patent_doc_number] => 05616491 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-01 [patent_title] => 'Knockout mice' [patent_app_type] => 1 [patent_app_number] => 8/528363 [patent_app_country] => US [patent_app_date] => 1995-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 13 [patent_no_of_words] => 9914 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/616/05616491.pdf [firstpage_image] =>[orig_patent_app_number] => 528363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3621911 [patent_doc_number] => 05602025 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-11 [patent_title] => 'Non-tumorigenic cell lines for expression of genes' [patent_app_type] => 1 [patent_app_number] => 8/468195 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 4875 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/602/05602025.pdf [firstpage_image] =>[orig_patent_app_number] => 468195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3774624 [patent_doc_number] => 05849996 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'BCR/ABL transgenic animals as models for Philadelphia chromosome positive chronic myelogenous and acute lymphoblastic leukemia' [patent_app_type] => 1 [patent_app_number] => 8/463467 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 17 [patent_no_of_words] => 9078 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849996.pdf [firstpage_image] =>[orig_patent_app_number] => 463467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3567668 [patent_doc_number] => 05538713 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-23 [patent_title] => 'Primordial implants in immunodeficient hosts' [patent_app_type] => 1 [patent_app_number] => 8/462766 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3373 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/538/05538713.pdf [firstpage_image] =>[orig_patent_app_number] => 462766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3509121 [patent_doc_number] => 05569812 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-29 [patent_title] => 'Nude mouse model for human neoplastic disease' [patent_app_type] => 1 [patent_app_number] => 8/459730 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5507 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/569/05569812.pdf [firstpage_image] =>[orig_patent_app_number] => 459730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3722894 [patent_doc_number] => 05670134 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'Method for evaluating and modifying biological activity' [patent_app_type] => 1 [patent_app_number] => 8/456330 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7525 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670134.pdf [firstpage_image] =>[orig_patent_app_number] => 456330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3657988 [patent_doc_number] => 05591669 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-07 [patent_title] => 'Transgenic mice depleted in a mature lymphocytic cell-type' [patent_app_type] => 1 [patent_app_number] => 8/454034 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 24 [patent_no_of_words] => 15212 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/591/05591669.pdf [firstpage_image] =>[orig_patent_app_number] => 454034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3536538 [patent_doc_number] => 05557032 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-17 [patent_title] => 'Knockout mice' [patent_app_type] => 1 [patent_app_number] => 8/451691 [patent_app_country] => US [patent_app_date] => 1995-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9910 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/557/05557032.pdf [firstpage_image] =>[orig_patent_app_number] => 451691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3665295 [patent_doc_number] => 05625127 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-29 [patent_title] => 'Extended human hematopoiesis in a heterologous host' [patent_app_type] => 1 [patent_app_number] => 8/434706 [patent_app_country] => US [patent_app_date] => 1995-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2349 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/625/05625127.pdf [firstpage_image] =>[orig_patent_app_number] => 434706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3644188 [patent_doc_number] => 05639440 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-17 [patent_title] => 'Method for evaluating immunogenicity' [patent_app_type] => 1 [patent_app_number] => 8/428932 [patent_app_country] => US [patent_app_date] => 1995-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7582 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/639/05639440.pdf [firstpage_image] =>[orig_patent_app_number] => 428932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3603945 [patent_doc_number] => 05589155 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-31 [patent_title] => 'Mutagenesis testing using transgenic non-human animals carrying test DNA sequences' [patent_app_type] => 1 [patent_app_number] => 8/398933 [patent_app_country] => US [patent_app_date] => 1995-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 7878 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/589/05589155.pdf [firstpage_image] =>[orig_patent_app_number] => 398933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4005258 [patent_doc_number] => 05888774 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Recombinant DNA molecules and expression vectors for erythropoietin' [patent_app_type] => 1 [patent_app_number] => 8/358918 [patent_app_country] => US [patent_app_date] => 1994-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15273 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/888/05888774.pdf [firstpage_image] =>[orig_patent_app_number] => 358918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3620946 [patent_doc_number] => 05688773 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-18 [patent_title] => 'Method of selectively destroying neoplastic cells' [patent_app_type] => 1 [patent_app_number] => 8/330523 [patent_app_country] => US [patent_app_date] => 1994-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 46 [patent_no_of_words] => 35903 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/688/05688773.pdf [firstpage_image] =>[orig_patent_app_number] => 330523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3495548 [patent_doc_number] => 05532158 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-02 [patent_title] => 'Interleukin-2 receptor deficient mammals' [patent_app_type] => 1 [patent_app_number] => 8/326896 [patent_app_country] => US [patent_app_date] => 1994-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 9371 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/532/05532158.pdf [firstpage_image] =>[orig_patent_app_number] => 326896 [rel_patent_id] =>[rel_patent_doc_number] =>)